The cytoskeletal protein hematopoietic‐specific protein 1 (HS1) is known as a critical component of CLL pathophysiology, with cytoskeletal remodeling representing a critical early event following BCR engagement, discussed also in later chapters [79, 80]. Here, BCR is linked to B-cell chronic lymphocytic leukemia.